Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959
…, DJ Bushnell, PH Crackett, SJ Dunsdon…
Index: Parkes, Kevin E. B.; Bushnell, David J.; Crackett, Peter H.; Dunsdon, Stephen J.; Freeman, Andrew C.; et al. Journal of Organic Chemistry, 1994 , vol. 59, # 13 p. 3656 - 3664
Full Text: HTML
Citation Number: 124
Abstract
Ro 31-8959 (11, a potent and selective inhibitor of HIV proteinase, is currently in phase I11 clinical trials. Six approaches for the large-scale synthesis of this compound have been studied. All routes employ an initial disconnection to an electrophilic L-phenylalanine homologue equivalent 13 and the decahydroisoquinoline derivative 5. They differ in adopting either an epoxide, a cyclic sulfate, or an aldehyde as the electrophilic entity and ...
Related Articles:
[Journal of Medicinal Chemistry, , vol. 46, # 9 p. 1764 - 1768]
Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959
[Journal of Organic Chemistry, , vol. 59, # 13 p. 3656 - 3664]
[Journal of Medicinal Chemistry, , vol. 37, # 8 p. 1177 - 1188]
[Journal of Medicinal Chemistry, , vol. 46, # 9 p. 1764 - 1768]
Development of a new type of protease inhibitors, efficacious against FIV and HIV variants
[Journal of the American Chemical Society, , vol. 121, # 6 p. 1145 - 1155]